Alıntılar

APA (7. basım) Alıntı
Rey, V., Tornín, J., Alba-Linares, J. J., Robledo, C., Murillo, D., Rodríguez, A., . . . Rodríguez, R. (2024). A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcomaResearch in context. Elsevier.
Chicago Style (17. basım) Atıf
Rey, Verónica, et al. A Personalized Medicine Approach Identifies Enasidenib as an Efficient Treatment for IDH2 Mutant ChondrosarcomaResearch in Context. Elsevier, 2024.
MLA (9th ed.) Atıf
Rey, Verónica, et al. A Personalized Medicine Approach Identifies Enasidenib as an Efficient Treatment for IDH2 Mutant ChondrosarcomaResearch in Context. Elsevier, 2024.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..